One Health meets clinical trials manufacturing and the new EU Biotech Act (2025)

This article highlights the increasing importance of One Health to industrial operations, considering that regulations are being amended and created with its principles in mind. One Health recognises the interconnectedness of human, animal and environmental health.

One Health addresses health threats at the human-environment-animal interface. An interdisciplinary approach will converge One Health with clinical trials, pharmaceutical and medical device manufacturing. The One Health approach is gaining worldwide attention.

The European Commission Directorate-General for Health and Food Safety published news on 31st March 2025 concerning applying One Health governance to their policies. The European Medicines Agency (EMA) says it ‘and four other health and environment agencies of the European Union (EU) work together to implement the One Health approach. It aims to enable the EU and its Member States to better prevent, predict, detect and respond to health threats.’

In Europe, five agencies make up the One Health task force:

1. EMA for medicines.
2. ECDC for disease prevention and control.
3. ECHA for chemicals.
4. EEA for the environment.
5. EFSA for food safety and sustainability.

These five EU agencies published One Health: a joint framework for action, which aims to strengthen cooperation to support the implementation of the One Health agenda in the EU.